Directory
>
Michael Karol
Michael Karol
Executive Director and Head, Clinical Pharmacology and Drug Metabolism - Retired
Cambridge, Massachusetts, United States
Michael Karol
Summary
Michael Karol is an accomplished executive in the pharmaceutical industry, currently serving as the Executive Director and Head of Clinical Pharmacology and Drug Metabolism at Sumitomo Dainippon Pharma Oncology. With a robust background in clinical pharmacology, he has held significant roles at notable companies such as Millennium Pharmaceuticals and Abbott Laboratories. His academic foundation includes a PhD from Purdue University and a Bachelor's degree in Pharmacy from the University of Colorado, Boulder. Michael's career spans over three decades, showcasing his deep expertise in drug metabolism and clinical development. He is recognized for his strategic leadership and innovative approach to drug discovery and development, which has significantly contributed to advancing therapeutic options in oncology. His passion for improving patient outcomes drives his professional endeavors, making him a key player in the pharmaceutical landscape.
Michael Karol
Work Experience
Executive Director and Head, Clinical Pharmacology and Drug Metabolism - Retired at
Sumatomo Pharma Oncology
February 2018 - March 2023
Executive Director, Clinical Pharmacology and Pharmacometrics at
Retrophin, LLC
July 2017 - February 2018
Senior Director, Clinical Pharmacology and Pharmacometrics at
Retrophin, LLC
April 2016 - June 2017
Senior Director, Clinical Pharmacology and Pharmacometrics at
Synta Pharmaceuticals
January 2008 - November 2015
Director, Clinical Pharmacology at
Takeda Oncology
January 2004 - January 2008
Section Manager (Volwiler Associate Research Fellow), Clinical Pharmacokinetics at
Abbott Co
January 1989 - January 2004
Assistant Professor, Pharmaceutical Sciences, College of Pharmacy at
The University Of Arizona
January 1984 - January 1989
Michael Karol
Education
Purdue University, Phd
University of Colorado Boulder, Bachelor’s Degree
Frequently Asked Questions about Michael Karol
What is Michael Karol email address?
Michael Karol's primary email address is ******@bostonbiomedical.com. To view the full verified email and additional contact details, sign up for free with Muraena.
Where Michael Karol graduated from?
Michael Karol holds a degree in from Purdue University.
How can I directly contact Michael Karol?
To contact Michael Karol directly, you can use the email address ******@bostonbiomedical.com. Complete contact information is available upon registration with Muraena.
Who is Michael Karol?
Michael Karol is an accomplished executive in the pharmaceutical industry, currently serving as the Executive Director and Head of Clinical Pharmacology and Drug Metabolism at Sumitomo Dainippon Pharma Oncology. With a robust background in clinical pharmacology, he has held significant roles at notable companies such as Millennium Pharmaceuticals and Abbott Laboratories. His academic foundation includes a PhD from Purdue University and a Bachelor's degree in Pharmacy from the University of Colorado, Boulder. Michael's career spans over three decades, showcasing his deep expertise in drug metabolism and clinical development. He is recognized for his strategic leadership and innovative approach to drug discovery and development, which has significantly contributed to advancing therapeutic options in oncology. His passion for improving patient outcomes drives his professional endeavors, making him a key player in the pharmaceutical landscape.
Michael`s contact details
******@bostonbiomedical.com
*************@retrophin.com
******@syntapharma.com